IN2014MU00386A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00386A
IN2014MU00386A IN386MU2014A IN2014MU00386A IN 2014MU00386 A IN2014MU00386 A IN 2014MU00386A IN 386MU2014 A IN386MU2014 A IN 386MU2014A IN 2014MU00386 A IN2014MU00386 A IN 2014MU00386A
Authority
IN
India
Prior art keywords
salts
benzazepine
tetrahydro
chloro
methyl
Prior art date
Application number
Other languages
English (en)
Inventor
Shri Prakash Dhar Dwivedi
Jayprakash Ajitsingh Parihar
Alpesh Pravinchandra Shah
Samir Rameshbhai Gajjar
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN386MU2014 priority Critical patent/IN2014MU00386A/en
Publication of IN2014MU00386A publication Critical patent/IN2014MU00386A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN386MU2014 2014-02-04 2014-02-04 IN2014MU00386A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN386MU2014 IN2014MU00386A (enExample) 2014-02-04 2014-02-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN386MU2014 IN2014MU00386A (enExample) 2014-02-04 2014-02-04

Publications (1)

Publication Number Publication Date
IN2014MU00386A true IN2014MU00386A (enExample) 2015-09-25

Family

ID=54393764

Family Applications (1)

Application Number Title Priority Date Filing Date
IN386MU2014 IN2014MU00386A (enExample) 2014-02-04 2014-02-04

Country Status (1)

Country Link
IN (1) IN2014MU00386A (enExample)

Similar Documents

Publication Publication Date Title
MY197700A (en) Compounds useful for inhibiting cdk7
NZ747259A (en) Soluble c5ar antagonists
PH12016501966B1 (en) Compounds and compositions as toll-like receptor 7 agonists
MX2018007704A (es) Composicion farmaceutica que comprende lenalidomida amorfa y un antioxidante.
TW201613859A (en) Analogs of PRIDOPIDINE, their preparation and use
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
MY194262A (en) Inhibitors of ret
PH12017502255B1 (en) Nrf2 regulators
MX2016016593A (es) Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos.
MY173521A (en) Trpv4 antagonists
PH12020550616A1 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
MX2017005484A (es) Compuestos antagonistas del receptor de dopamina d3.
MX2020011668A (es) Antagonistas duales de receptores de neurocinina-1 (nk-1)/neurocinina-3 (nk-3) para el tratamiento de enfermedades dependientes de hormonas sexuales.
NZ734400A (en) Amide compounds as 5-ht4 receptor agonists
MX2017001103A (es) Derivados de indolizina que son aplicables a enfermedades neurodegenerativas.
MX2021001786A (es) Antagonistas de integrina.
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2015011536A (es) Nuevos antagonistas de receptores trpa1 de sulfamidas.
PH12017501876A1 (en) Pyridopyrimidones and their use as nmda receptor modulators
MX380037B (es) Antagonistas novedosos 5-ht2
MY176521A (en) Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising the same and use thereof
WO2015001541A3 (en) Pharmaceutical film composition
IN2014CH00840A (enExample)
PH12017501736B1 (en) Indole derivatives
NZ741384A (en) Dopamine d3 receptor antagonists having a morpholine moiety